Part 1Preliminary1Short titleThis regulation may be cited as the Public Health (Medicinal Cannabis) and Other Legislation Amendment Regulation 2018.Part 2Amendment of Health (Drugs and Poisons) Regulation 19962Regulation amendedThis part amends the Health (Drugs and Poisons) Regulation 1996.3Amendment of s 78A (Approved drug–nabiximols)(1)Section 78A(1)(b)—omit.(2)Section 78A(1)(c)(i), ‘prescribed’—omit, insert—compliant(3)Section 78A(1)(c)—renumber as section 78A(1)(b).(4)Section 78A(2), from ‘practitioner,’—omit, insert—practitioner includes a registrar working under the direction of a specialist medical practitioner.(5)Section 78A(3)—insert—chronic non-cancer pain means pain, persisting more than 3 months, that is not associated with cancer.(6)Section 78A(3), definition prescribed patient—insert—

(e)a person experiencing chronic non-cancer pain.

(7)Section 78A(3), definition prescribed specialist medical practitioner—omit.4Amendment of s 78B (Exemptions for some acts involving regulated controlled drugs)Section 78B(2) to (4)—omit.Part 3Amendment of Public Health (Medicinal Cannabis) Regulation 20175Regulation amendedThis part amends the Public Health (Medicinal Cannabis) Regulation 2017.6Amendment of s 27 (Form of wholesaling approval)Section 27(a), ‘and professional qualifications’—omit.7Amendment of s 54 (Prescribed specialist medical practitioners—Act, s 52(1)(a))Section 54(1)—omit, insert—(1)For section 52(1)(a) of the Act, all compliant specialist medical practitioners are prescribed.8Amendment of s 55 (Prescribed classes of patients—Act, s 52(2)(a))(1)Section 55(1)—insert—

(e)persons experiencing chronic non-cancer pain.

(2)Section 55(2)—insert—chronic non-cancer pain means pain, persisting more than 3 months, that is not associated with cancer.9Amendment of s 89 (Dealing with prescriptions)Section 89(4), ‘72 hours’—omit, insert—7 days10Amendment of s 127 (Patient-class prescribers)Section 127(2)—omit, insert—(2)If the chief executive requests that a patient-class prescriber provide a treatment report for an eligible patient the patient-class prescriber is treating with medicinal cannabis, the patient-class prescriber must provide the report to the chief executive within the time stated in the request.Maximum penalty—20 penalty units.